Temasek Holdings’s Juno Therapeutics, Inc. JUNO Stock Holding History

Temasek Holdings’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-915,750	Closed	-$41.9M	–	71
2017 Q4	$41.9M	Hold	915,750	–	–	0.26%	39
2017 Q3	$41.1M	Hold	915,750	–	–	0.24%	34
2017 Q2	$27.4M	Hold	915,750	–	–	0.18%	34
2017 Q1	$20.3M	Hold	915,750	–	–	0.15%	31
2016 Q4	$17.3M	Hold	915,750	–	–	0.14%	33
2016 Q3	$27.5M	Hold	915,750	–	–	0.22%	23
2016 Q2	$35.2M	Hold	915,750	–	–	0.28%	21
2016 Q1	$34.9M	Hold	915,750	–	–	0.27%	23
2015 Q4	$40.3M	Hold	915,750	–	–	0.31%	21
2015 Q3	$37.3M	Hold	915,750	–	–	0.35%	18
2015 Q2	$48.8M	Hold	915,750	–	–	0.31%	21
2015 Q1	$55.5M	Hold	915,750	–	–	0.42%	14
2014 Q4	$47.8M	Buy	+915,750	New	+$41M	0.5%	15

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Temasek Holdings's JUNO Position: Q1 2018 in Review

Temasek Holdings sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 915,750 shares — an estimated $41.9M sold.

Temasek Holdings first reported a position in JUNO in Q4 2014 and held it in 13 quarters. The position peaked at $55.5M in Q1 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Temasek Holdings reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Temasek Holdings sold 915,750 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $41.9M.
Temasek Holdings first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 13 quarters.
Temasek Holdings's Juno Therapeutics, Inc. position peaked at $55.5M in Q1 2015.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Temasek Holdings's 13F filing for Q1 2018, filed 15 May 2018.